Marine Algae as a Natural Source for Antiviral Compounds
DOI:
https://doi.org/10.21467/preprints.38Abstract
Coronavirus or COVID-19 is started from the China, Wuhan city in December 2019 and soon later, spread around 190 countries and declared as pandemic on March 11, 2020 by WHO. Healthcare systems all over the world are fighting against this pandemic. Most of the countries are lockdown for uncertain periods to protect their people from this pandemic as a result the world economy is struggling to cope up with the current situation. Several countries have conducted research studies to produce vaccine or antiviral drug but there is still no specific solution for the prevention or treatment of COVID-19 infection in general. Along with other treatment methods, many countries are fuelling their demand for antiviral compounds from natural resources due to coronavirus. Microalgae and cyanobacteria are excellent source of antiviral activity. Several cyclic or linear peptides and depsipeptides isolated from cyanobacteria are protease inhibitors, which is considered as significant antiviral candidate. Micro and macroalgae were one of the first sources of natural compounds showing in vitro anti-HIV activity. Numerous in vitro or in vivo studies has shown the potential of algae against wild range of viruses. The use of natural products in the manufacturing of drugs is an ancient and well-established practice. Marine microorganisms are known producers of pharmacological and anti-viral agents and may provide unlimited biological resources to produce therapeutic drugs for the treatment and control of viral diseases in humans. Our major intention to write this review to bring world’s attention in terms of public health and public policy practices across the world to grab an opportunity from this known healthcare practices, and conventional platform to produce vaccine or antiviral medicine to overcome COID-19.
Keywords:
Corona, COVID-19, Pandemic, Antiviral, Public health, Algae, compoundsDownloads
References
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.
Gorbalenya, A. E. et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology 2020, DOI: 10.1038/s41564-020-0695-z
World Health Organization. Coronavirus disease (COVID-19) Pandemic Geneva: World Health 311 Organization; 2020.
World Health Organization. Coronavirus disease 2019 (COVID-19): Situation Report – 51. 2020.
Kupferschmidt, K.; Cohen, J. Will novel virus go pandemic or be contained? Science 2020, 367 (6478), 610?611.
Coronavirus is now expected to curb global economic growth by 0.3% in 2020. https://www.forbes.com/
Anthony, S. J.; Johnson, C. K.; Greig, D. J.; Kramer, S.; Che, X.; Wells, H.; Hicks, A. L.; Joly, D. O.; Wolfe, N. D.; Daszak, P.; Karesh, W.; Lipkin, W. I.; Morse, S. S.; Mazet, J. A. K.; Goldstein, T. Global patterns in coronavirus diversity. Virus Evol 2017, 3 (1), vex012.
Skulberg, O.M., 2004. Bioactive chemicals in microalgae. In: Richmond, A. (Ed.), Handbook of microalgal culture: biotechnology and applied phycology.Blackwell Science Ltd., Oxford, pp. 485–512.
Singh, S., Kate, B.N., Banerjee, U.C., 2005. Bioactive compounds from cyanobacteria
and microalgae: an overview. Crit. Rev. Biotechnol. 25, 73–95.
Schaeffer, D.J., Krylov, V.S., 2000. Anti-HIV activity of extracts and compounds from
algae and cyanobacteria. Ecotoxicol. Environ. Saf. 45, 208–227.
Pratt, R., Fong, J., 1940. Studies on Chlorella vulgaris. Further evidence that chlorella
cells form a growth inhibiting substance. Am. J. Bot. 27, 431–436.
Pratt, R., Mautner, R.H., Gardner, G.M., Sha, Y., Dufenoy, J., 1951. Report on antibiotic activity of seaweed extracts. J. Am. Pharm. Assoc. 40, 575–579.
Silva et al. (2018), Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity. PeerJ 6:e5716; DOI 10.7717/peerj.5716.
P. Gerber, J. D. Dutcher, E. V. Adams, and J.H. Sherman, “Protective effect of seaweed extracts for chicken embryos infected with influenza B or mumps virus,” Experimental Biology and Medicine, vol. 99, no. 3, pp. 590–593, 1958.
P. R. Burkholder and G.M. Sharma, “Antimicrobial agents from the sea,” Lloydia, vol. 32, no. 4, pp. 466–483, 1969.
E. F. Deig, D.W. Ehresmann, M. T. Hatch, and D. J. Riedlinger, “Inhibition of herpesvirus replication bymarine algae extracts,” Antimicrobial Agents and Chemotherapy, vol. 6, no. 4, pp. 524–525, 1974.
D.W. Ehresmann, E. F. Deig,M. T. Hatch, L. H. DiSalvo, and N.A. Vedros, “Antiviral substances from California marine algae,” Journal of Phycology, vol. 13, no. 1, pp. 37–40, 1977.
J.T. Richards, E.R.Kern, L. A. Glasgow, J. C.Overall, E. F.Deign, and M. T. Hatch, “Antiviral activity of extracts from marine algae,” Antimicrobial Agents and Chemotherapy, vol. 14, no. 1, pp. 24–30, 1978.
Jarred Yasuhara-Bell, Yuanan Lu. Marine compounds and their antiviral activities. Antiviral Research 86 (2010) 231–240
Hasui, M., Matsuda, M., Okutani, K., Shigeta, S., 1995. In vitro antiviral activities of
sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses. Int. J. Biol. Macromol. 17, 293–297.
Pereira, H.S., Leao-Ferreira, L.R., Moussatche, N., Teixeira, V.L., Cavalcanti, D.N., Costa, L.J., Diaz, R., Frugulhetti, I.C., 2004. Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 64, 69–76.
Hayashi, T., Hayashi, K., Maeda, M., Kojima, I., 1996. Calcium spirulan, an inhibitorof enveloped virus replication, from a blue–green alga Spirulina platensis. J. Nat.
Prod. 59, 83–87.
Boyd, M.R., Gustafson, K., McMahon, J., Shoemaker, R., 1996. Discovery of cyanovirin-N, a novel HIV-inactivating protein from Nostoc ellipsosporum that targets viral gp120. Int. Conf. AIDS 11, 71.
Béress, A., Wassermann, O., Bruhn, T., Béress, L., Kraiselburd, E.N., Gonzalez, L.V.,
de Motta, G.E., Chavez, P.I., 1993. A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucus vesiculosus. J. Nat. Pros. 56, 478–488.
Moen, L.K., Clark, G.F., 1993. A novel reverse transcriptase inhibitor from Fucus
vesiculosus. Int. Conf. AIDS 9, 145–161.
Witvrouw, M., Este, J.A., Quinones Mateu, M.E., Reymen, D., Andrei, G., Snoeck, R.,
Ikeda, S., Pauwels, R., Vittori Bianchini, N., Desmyter, J., De Clercq, E., 1994. Antiviral activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped
viruses. Antiviral Chem. Chemother. 5, 297–303.
Mori, T., O’Keefe, B.R., Sowder, R.C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J.A., Buckheit Jr., R.W., McMahon, J.B., Boyd, M.R., 2005. Isolation and
characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 280, 9345–9353.
Lee, J.B., Hayashi, K., Hirata, M., Kuroda, E., Suzuki, E., Kubo, Y., Hayashi, T., 2006.
Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from
deep-sea water in Toyama Bay. Biol. Pharm. Bull. 29, 2135–2139.
Nakashima, H., Kido, Y., Kobayashi, N., Motoki, Y., Neushul, M., Yamamoto, N.,
a. Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides
extracted from sea algae. Antimicrob. Agents Chemother. 31,1524–1528.
Nakashima, H., Kido, Y., Kobayashi, N., Motoki, Y., Neushul, M., Yamamoto, N., 1987b. Antiretroviral activity in a marine red alga: Reverse transcriptase inhibition
by an aqueous extract of Schizymenia pacifica. J. Cancer Res. Clin. Oncol. 113, 413–416.
Roussis, V., 2005. Preface. Phytochemi. Rev. 3, 265.
Tziveleka, L.A., Vagias, C., Roussis, V., 2003. Natural products with anti-HIV activity
from marine organisms. Curr. Top. Med. Chem. 3, 1512–1535.
Bhadury, P., Mohammad, B.T., Wright, P.C., 2006. The current status of natural products from marine fungi and their potential as anti-infective agents. J. Ind. Microbiol. Biotechnol. 33, 325–337.
Narges Mohammadi, neda shaghaghi. Inhibitory Effect of Eight Secondary Metabolites from Conventional Medicinal Plants on COVID_19 Virus Protease by Molecular Docking Analysis. doi.org/10.26434/chemrxiv.11987475.v1
C R K Reddy, G Raja Krishna Kumar, A K Siddhanta, A Tewari. and K Eswaran, 2003. In vitro somatic embryogenesis and regeneration of somatic embryos from pigmented callus of Kappaphycus alvarezii (Doty) Doty (Rhodophyta, Gigartinales)" Journal of Phycology, 39: 610-616
US Patent No. 6858430 B1, issued February 22, 2005. C R K Reddy, O P Mairh, G. Raja Krishna Kumar, K. Eswaran, P V Subba Rao, K. H. Mody and P K. Ghosh. An Improved Process for Cultivation of Algae.
Gaikwad M.S; Meshram B.G; Chaugule B.B. 2009. On occurrence of the genus Porphyridium nageli: New to India. J. Algal Biomass Utln. 1 (1): 102 – 106.
Downloads
Posted
Section
Categories
License
Copyright (c) 2020 Amar S Musale, Raja Krishna Kumar G., Ajit Sapre, Santanu Dasgupta
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any non-commercial use, distribution, adaptation, and reproduction in any medium is permitted as long as the original work is properly cited. However, caution and responsibility are required when reusing as the articles on the preprint server are not peer-reviewed. Readers are advised to check for the availability of any updated or peer-reviewed version.
